scholarly journals Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan

2020 ◽  
Vol 22 (1) ◽  
Author(s):  
Tsutomu Takeuchi ◽  
Yoshiya Tanaka ◽  
Sakae Tanaka ◽  
Atsushi Kawakami ◽  
Yeong-Wook Song ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Extension Study ◽  
Open Label ◽  
Open Label Extension

scholarly journals An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis

2019 ◽  
Vol 21 (1) ◽  
Author(s):  
Stanley Cohen ◽  
Jose L. Pablos ◽  
Karel Pavelka ◽  
Gerard Anton Müller ◽  
Alan Matsumoto ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Extension Study ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension ◽  
Abp 501
Sign in / Sign up

Export Citation Format

Share Document